Long-term study results are currently limited, but the following must be considered for shaping the clinical algorithm in GLP-1 RA prescribing: proper indication, the characteristics of the prescribed drug, the patient's psychiatric and somatic history, sociodemographic factors, patient expectations, and especially monitoring of response to rapid weight loss (Figure 1)
FIGURE 8 Discussion DR is one of the leading causes of blindness among people of working age worldwide (Klein, 2007) and may become a great challenge for healthcare systems in the future (Selvaraj et al., 2017)
If nausea is a significant concern, trying a different injection site before adjusting your dose is a reasonable first step
Declared that medications should be used alongside intensive behavioral therapy , not instead of it, says John